Search by Drug Name or NDC
NDC 47781-0925-01 pyrimethamine 25 mg/1 Details
pyrimethamine 25 mg/1
pyrimethamine is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Alvogen Inc.. The primary component is PYRIMETHAMINE.
Product Information
| NDC | 47781-0925 |
|---|---|
| Product ID | 47781-925_d72499da-4d6d-48f6-cd6d-4351ac2a1433 |
| Associated GPIs | 13000040000310 |
| GCN Sequence Number | 009579 |
| GCN Sequence Number Description | pyrimethamine TABLET 25 MG ORAL |
| HIC3 | W4A |
| HIC3 Description | ANTIMALARIAL DRUGS |
| GCN | 42930 |
| HICL Sequence Number | 004150 |
| HICL Sequence Number Description | PYRIMETHAMINE |
| Brand/Generic | Generic |
| Proprietary Name | pyrimethamine |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | pyrimethamine |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 25 |
| Active Ingredient Units | mg/1 |
| Substance Name | PYRIMETHAMINE |
| Labeler Name | Alvogen Inc. |
| Pharmaceutical Class | Dihydrofolate Reductase Inhibitor Antimalarial [EPC], Dihydrofolate Reductase Inhibitors [MoA] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA211271 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 47781-0925-01 (47781092501)
| NDC Package Code | 47781-925-01 |
|---|---|
| Billing NDC | 47781092501 |
| Package | 100 TABLET in 1 BOTTLE (47781-925-01) |
| Marketing Start Date | 2021-09-17 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |